Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE

Eleonora Pelle1, Taymeyah Al-Toubah1, Ghassan El-Haddad2

  • 1Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Abstract